KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Other financing activities (2016 - 2025)

Historic Other financing activities for Teladoc Health (TDOC) over the last 10 years, with Q3 2025 value amounting to $4.1 million.

  • Teladoc Health's Other financing activities rose 168648.65% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 23980.42%. This contributed to the annual value of -$2000.0 for FY2024, which is 9928.06% up from last year.
  • Per Teladoc Health's latest filing, its Other financing activities stood at $4.1 million for Q3 2025, which was up 168648.65% from $176000.0 recorded in Q4 2024.
  • In the past 5 years, Teladoc Health's Other financing activities registered a high of $4.1 million during Q3 2025, and its lowest value of -$9.4 million during Q3 2021.
  • Moreover, its 5-year median value for Other financing activities was $104000.0 (2024), whereas its average is -$419117.6.
  • As far as peak fluctuations go, Teladoc Health's Other financing activities plummeted by 33505.75% in 2022, and later skyrocketed by 168648.65% in 2025.
  • Teladoc Health's Other financing activities (Quarter) stood at -$842000.0 in 2021, then soared by 292.64% to $1.6 million in 2022, then crashed by 277.99% to -$2.9 million in 2023, then soared by 106.1% to $176000.0 in 2024, then surged by 2234.66% to $4.1 million in 2025.
  • Its Other financing activities stands at $4.1 million for Q3 2025, versus $176000.0 for Q4 2024 and -$259000.0 for Q3 2024.